These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12956548)

  • 41. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
    Miner JR; Moore J; Gray RO; Skinner L; Biros MH
    Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Which tobramycin dose is needed in the burn patient?
    Arnould JF; Le floch R; Pilorget A
    Burns; 2009 Sep; 35(6):904; author reply 904-5. PubMed ID: 19423229
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
    Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen.
    Kamel Mohamed OH; Wahba IM; Watnick S; Earle SB; Bennett WM; Ayres JW; Munar MY
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):694-9. PubMed ID: 17699484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: a pilot project.
    Coates AL; Green M; Leung K; Chan J; Ribeiro N; Louca E; Ratjen F; Charron M; Tservistas M; Keller M
    Pediatr Pulmonol; 2008 Aug; 43(8):753-9. PubMed ID: 18613006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: an intervention study.
    McLaughlin CM; Bodasing N; Boyter AC; Fenelon C; Fox JG; Seaton RA
    QJM; 2005 Oct; 98(10):745-52. PubMed ID: 16126741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple Intravenous Infusions Phase 2a: Ontario Survey.
    Fan M; Koczmara C; Masino C; Cassano-Piché A; Trbovich P; Easty A
    Ont Health Technol Assess Ser; 2014; 14(4):1-141. PubMed ID: 26257837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of combined tobramycin-clarithromycin on Mycobacterium tuberculosis isolates.
    Stoffels K; Traore H; Vanderbist F; Fauville-Dufaux M
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):1041-4. PubMed ID: 19723387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
    Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
    Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delayed delivery of antibiotics by retrograde intravenous infusion.
    Nahata MC
    Am J Hosp Pharm; 1986 Sep; 43(9):2237-9. PubMed ID: 3766583
    [No Abstract]   [Full Text] [Related]  

  • 51. Optimizing bactericidal exposure for beta-lactams using prolonged and continuous infusions in the pediatric population.
    Courter JD; Kuti JL; Girotto JE; Nicolau DP
    Pediatr Blood Cancer; 2009 Sep; 53(3):379-85. PubMed ID: 19422028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The implications of nurse i.v. drug administration.
    Grundy M
    Prof Nurse; 1996 Dec; 12(3):207-12. PubMed ID: 9128669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preparing antibiotics for infusion: not as simple as it appears!].
    Panknin HT
    Kinderkrankenschwester; 2008 Apr; 27(4):167-8. PubMed ID: 18481471
    [No Abstract]   [Full Text] [Related]  

  • 54. Small-Volume Injections: Evaluation of Volume Administration Deviation From Intended Injection Volumes.
    Muffly MK; Chen MI; Claure RE; Drover DR; Efron B; Fitch WL; Hammer GB
    Anesth Analg; 2017 Oct; 125(4):1192-1199. PubMed ID: 28338490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can variable practice habits and injection port dead-volume put patients at risk?
    Kuntz MT; Dudaryk R; McNeer RR
    J Clin Monit Comput; 2019 Aug; 33(4):549-556. PubMed ID: 29992507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retrograde medication administration--a predictable and simple system for pediatric drug delivery.
    Lunn JK; Wilson A
    Focus Crit Care; 1986 Dec; 13(6):59-63. PubMed ID: 3641754
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of various infusion pump administration techniques and rates on tobramycin delivery.
    Cacek AT; Moore JE; Bishop TS
    Am J Hosp Pharm; 1988 Nov; 45(11):2381-3. PubMed ID: 3228098
    [No Abstract]   [Full Text] [Related]  

  • 58. Routine early therapeutic drug monitoring is necessary during the first week of life.
    Stolk LM; Guillaume C
    Clin Pharmacol Ther; 2003 Jan; 73(1):131; author reply 131-2. PubMed ID: 12545151
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of intravenous infusion dead space on time to drug delivery in infants.
    Gregerson BG; Larsen AL; Kelly SM; Sonnier JD; Juergens AL
    Proc (Bayl Univ Med Cent); 2018 Apr; 31(2):168-170. PubMed ID: 29706809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intermittent I.V. infusions in acute care: special considerations.
    Weeks KA
    Nursing; 2012 Dec; 42(12):66-8. PubMed ID: 23172070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.